In regard to cancer, numerous previous studies have shown that Sp1 levels were elevated in various types of human cancers, including lung [11], colorectal [12], gastric [13] and pancreatic ductal adenocarcinoma [14], correlating with aggressive biological activity and poor clinical outcomes [13, 15]. This evidence concerns the gene SP1 and cancer.